Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

NCT00197197 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to hepatoxicity of compound

Conditions

HIV Infection

Interventions

DRUG: GW873140

Sponsor

GlaxoSmithKline